Memorial Sloan-kettering Cancer Center - Net Worth and Insider Trading
Memorial Sloan-kettering Cancer Center Net Worth
The estimated net worth of Memorial Sloan-kettering Cancer Center is at least $295,130 dollars as of 2024-09-20. Memorial Sloan-kettering Cancer Center is the 10% Owner of Actinium Pharmaceuticals Inc and owns about 156,984 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $295,130. Details can be seen in Memorial Sloan-kettering Cancer Center's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Memorial Sloan-kettering Cancer Center has not made any transactions after 2016-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Memorial Sloan-kettering Cancer Center
Memorial Sloan-kettering Cancer Center Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Memorial Sloan-kettering Cancer Center owns 1 companies in total, including Actinium Pharmaceuticals Inc (ATNM) .
Insider Ownership Summary of Memorial Sloan-kettering Cancer Center
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATNM | Actinium Pharmaceuticals Inc | 2016-08-31 | 10 percent owner |
Memorial Sloan-kettering Cancer Center Latest Holdings Summary
Memorial Sloan-kettering Cancer Center currently owns a total of 1 stock. Memorial Sloan-kettering Cancer Center owns 156,984 shares of Actinium Pharmaceuticals Inc (ATNM) as of August 31, 2016, with a value of $295,130.
Latest Holdings of Memorial Sloan-kettering Cancer Center
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATNM | Actinium Pharmaceuticals Inc | 2016-08-31 | 156,984 | 1.88 | 295,130 |
Holding Weightings of Memorial Sloan-kettering Cancer Center
Memorial Sloan-kettering Cancer Center Form 4 Trading Tracker
According to the SEC Form 4 filings, Memorial Sloan-kettering Cancer Center has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the sale of 6,431 shares on August 31, 2016, which brought Memorial Sloan-kettering Cancer Center around $353,056.
Insider Trading History of Memorial Sloan-kettering Cancer Center
- 1
Memorial Sloan-kettering Cancer Center Trading Performance
Memorial Sloan-kettering Cancer Center Ownership Network
Memorial Sloan-kettering Cancer Center Owned Company Details
What does Actinium Pharmaceuticals Inc do?
Who are the key executives at Actinium Pharmaceuticals Inc?
Memorial Sloan-kettering Cancer Center is the 10 percent owner of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .
Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Actinium Pharmaceuticals Inc Insider Transactions
Memorial Sloan-kettering Cancer Center Mailing Address
Above is the net worth, insider trading, and ownership report for Memorial Sloan-kettering Cancer Center. You might contact Memorial Sloan-kettering Cancer Center via mailing address: 1275 York Ave., New York Ny 10065.